Sales & Marketing Views & Analysis

Views & Analysis

Sales & Marketing

KOL data for HCP engagement representation

Bad KOL data is expensive: Harnessing high-quality data for ...

As biopharmas increasingly rely on AI and advanced data-driven technologies, evaluating the quality of data is critical.

Sales & Marketing

Changing Faces: Board appointments in March 2025

One area in which March proved to be a busy month was in Board appointments, where both Boards of Directors and Advisory Boards saw a number of interesting additions.

Sales & Marketing

Executing established pharma brand strategy: Key considerati...

As blockbuster drug patents edge closer to expiry, pharma companies must rethink how they invest in, support, and scale established brands

Sales & Marketing

Solution Spotlight: iON.AI

iON.AI is a powerful, compliance-driven platform purpose-built for Medical Affairs, seamlessly blending human expertise with AI.

Sales & Marketing

illustrative concept for searching solutions, brainstorming and planning strategy

Harnessing zero‑party data: Transforming pharma advertising ...

Integrating zero-party data into ads, pharma and healthcare brands can revolutionise how they engage with patients

Sales & Marketing

Changing Faces – Board of Directors appointments – February ...

February saw several changes on boards at biotechs, bringing a diverse wealth of experience to support these companies.

Bad KOL data is expensive: Harnessing high-quality data for ...

Changing Faces: Board appointments in March 2025

Executing established pharma brand strategy: Key considerati...

Solution Spotlight: iON.AI

Harnessing zero‑party data: Transforming pharma advertising ...

Changing Faces – Board of Directors appointments – February ...

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

Views & Analysis

Editor's Picks